|
Peter H. Diamandis, MD, is a New York Times bestselling author and the cofounder of Singularity University, Human Longevity, Inc., Celularity, Inc., and founder of Bold Capital Partners. He is the founder and Executive Chairman of XPRIZE. Diamandis has degrees in molecular genetics and aerospace engineering from MIT and an MD from Harvard Medical School. Steven Kotler is a New York Times bestselling author, award-winning journalist and the Cofounder and Director of Research for the Flow Genome Project (FlowGenomeProject.co). |